Total Funding
24
43
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
123662
Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity.
Scott Schorer: President & Chief Executive Officer
Tom Vasicek: Co-Founder & CSOPast Role: Gila Therapeutics, Co-founder & Chief Executive Officer
About the Company
Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity. Using novel routes of administration, the company develops and commercializes medicines for metabolic diseases and targets a pathway to treat obesity by increasing fullness, decreasing caloric intake, and producing weight loss.
